In conclusion, our study utilized bioinformatics analysis and animal experiments to demonstrate that, in NSCLC, the expression of FLT3LG was significantly lower in tumor tissues than in normal tissues, and we observed a positive correlation between the degree of FLT3LG expression and patient prognosis. The gene discussed is FLT3LG; the disease is non-small cell lung carcinoma.